Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on January 9, 2018, covering events that occurred on January 7, 2018. The filing serves as a Regulation FD disclosure regarding investor presentations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is informational and does not contain financial statements or quantitative performance data.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The report solely documents the delivery of corporate presentations to investors and industry forums.
Guidance, Outlook, and Management Commentary
On January 7, 2018, company representatives presented slides at the Neuroscience Innovation Forum in San Francisco. On January 8, 2018, a corporate presentation was delivered to investors. Copies of these presentations are attached as Exhibits 99.01 and 99.02. The filing explicitly states that the information in these exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Neuralstem, Inc., not Palisade Bio, Inc.
- Review Exhibit 99.01 for details on the Neuroscience Innovation Forum presentation.
- Review Exhibit 99.02 for details on the investor corporate presentation.
- Note that forward-looking statements in the exhibits are not legally "filed" under the Exchange Act.